Drugs / GSK513026
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00307528 | Jan 2004 → Mar 2005 | — | GlaxoSmithKline | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | GSK513026 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00307528 ↗ |
| Modality | Vaccine | “new investigational pneumococcal protein vaccine” NCT00307528 ↗ |
| Route | Intramuscular | “Two-dose intramuscular injection.” NCT00307528 ↗ |